Preprint
Differences in systemic immune parameters in individuals with lung cancer according to race
bioRxiv : the preprint server for biology
Cold Spring Harbor laboratory
06/10/2024
DOI: 10.1101/2024.06.07.597754
PMCID: PMC11195092
PMID: 38915535
Abstract
Racial and ethnic disparities in the presentation and outcomes of lung cancer are widely known. To evaluate potential factors contributing to these observations, we measured systemic immune parameters in Black and White patients with lung cancer.IntroductionRacial and ethnic disparities in the presentation and outcomes of lung cancer are widely known. To evaluate potential factors contributing to these observations, we measured systemic immune parameters in Black and White patients with lung cancer.Patients scheduled to receive cancer immunotherapy were enrolled in a multi-institutional prospective biospecimen collection registry. Clinical and demographic information were obtained from electronic medical records. Pre-treatment peripheral blood samples were collected and analyzed for cytokines using a multiplex panel and for immune cell populations using mass cytometry. Differences between Black and White patients were determined and corrected for multiple comparisons.MethodsPatients scheduled to receive cancer immunotherapy were enrolled in a multi-institutional prospective biospecimen collection registry. Clinical and demographic information were obtained from electronic medical records. Pre-treatment peripheral blood samples were collected and analyzed for cytokines using a multiplex panel and for immune cell populations using mass cytometry. Differences between Black and White patients were determined and corrected for multiple comparisons.A total of 187 patients with non-small cell lung cancer (Black, 19; White, 168) were included in the analysis. There were no significant differences in baseline characteristics between Black and White patients. Compared to White patients, Black patients had significantly lower levels of CCL23 and CCL27, and significantly higher levels of CCL8, CXCL1, CCL26, CCL25, CCL1, IL-1 b, CXCL16, and IFN-γ (all P <0.05, FDR<0.1). Black patients also exhibited greater populations of non-classical CD16+ monocytes, NKT-like cells, CD4+ cells, CD38+ monocytes, and CD57+ gamma delta T cells (all P <0.05).ResultsA total of 187 patients with non-small cell lung cancer (Black, 19; White, 168) were included in the analysis. There were no significant differences in baseline characteristics between Black and White patients. Compared to White patients, Black patients had significantly lower levels of CCL23 and CCL27, and significantly higher levels of CCL8, CXCL1, CCL26, CCL25, CCL1, IL-1 b, CXCL16, and IFN-γ (all P <0.05, FDR<0.1). Black patients also exhibited greater populations of non-classical CD16+ monocytes, NKT-like cells, CD4+ cells, CD38+ monocytes, and CD57+ gamma delta T cells (all P <0.05).Black and White patients with lung cancer exhibit several differences in immune parameters, with Black patients exhibiting greater levels of numerous pro-inflammatory cytokines and cell populations. The etiology and clinical significance of these differences warrant further evaluation.ConclusionsBlack and White patients with lung cancer exhibit several differences in immune parameters, with Black patients exhibiting greater levels of numerous pro-inflammatory cytokines and cell populations. The etiology and clinical significance of these differences warrant further evaluation.
Details
- Title: Subtitle
- Differences in systemic immune parameters in individuals with lung cancer according to race
- Creators
- Mitchell S von Itzstein - The University of Texas Southwestern Medical CenterJialiang Liu - The University of Texas Southwestern Medical CenterHong Mu-Mosley - The University of Texas Southwestern Medical CenterFarjana Fattah - The University of Texas Southwestern Medical CenterJason Y Park - The University of Texas Southwestern Medical CenterJeffrey A SoRelle - The University of Texas Southwestern Medical CenterJ David FarrarMary E Gwin - The University of Texas Southwestern Medical CenterDavid Hsiehchen - The University of Texas Southwestern Medical CenterYvonne Gloria-McCutchen - The University of Texas Southwestern Medical CenterEdward K Wakeland - The University of Texas Southwestern Medical CenterSuzanne Cole - The University of Texas Southwestern Medical CenterSheena Bhalla - The University of Texas Southwestern Medical CenterRadhika Kainthla - The University of Texas Southwestern Medical CenterIgor Puzanov - Roswell Park Comprehensive Cancer CenterBenjamin Switzer - Roswell Park Comprehensive Cancer CenterGregory A Daniels - University of California San DiegoYousef Zakharia - University of IowaMontaser Shaheen - The University of Texas Health Science Center at San AntonioJianjun Zhang - The University of Texas MD Anderson Cancer CenterYang Xie - The University of Texas Southwestern Medical CenterDavid E Gerber - The University of Texas Southwestern Medical Center
- Resource Type
- Preprint
- Publication Details
- bioRxiv : the preprint server for biology
- DOI
- 10.1101/2024.06.07.597754
- PMID
- 38915535
- PMCID
- PMC11195092
- Publisher
- Cold Spring Harbor laboratory
- Language
- English
- Date posted
- 06/10/2024
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984649048002771
Metrics
9 Record Views